- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Takeda Pharmaceutical Co., Ltd. (TKPHF)Takeda Pharmaceutical Co., Ltd. stock price live, this page displays TYO 4502 stock exchange data. View the 4502 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Takeda Pharmaceutical Co., Ltd. real time stock price chart below.
What Is the Takeda Pharmaceutical Co., Ltd. Stock Price Today?
The Takeda Pharmaceutical Co., Ltd. stock price today is 27.365.
What Is the Stock Symbol for Takeda Pharmaceutical Co., Ltd.?
The stock symbol for Takeda Pharmaceutical Co., Ltd. is "4502."
What Stock Exchange Does Takeda Pharmaceutical Co., Ltd. Trade On?
Takeda Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Takeda Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Takeda Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4502 quote. (ISIN: JP3463000004)
What Is the Takeda Pharmaceutical Co., Ltd. Stock Price Today?
The Takeda Pharmaceutical Co., Ltd. stock price today is 27.365.
What Is the Stock Symbol for Takeda Pharmaceutical Co., Ltd.?
The stock symbol for Takeda Pharmaceutical Co., Ltd. is "4502."
What Stock Exchange Does Takeda Pharmaceutical Co., Ltd. Trade On?
Takeda Pharmaceutical Co., Ltd. is listed and trades on the Tokyo stock exchange.
Is Takeda Pharmaceutical Co., Ltd. a Good Stock to Buy?
Determining whether Takeda Pharmaceutical Co., Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4502 quote. (ISIN: JP3463000004)
27.365
+0.715(+2.70%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.365
27.600
52 wk Range
23.800
30.900
TKPHF Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.36527.600
52 wk Range
23.80030.900
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.39%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.39%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockTKPHF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
4,780.300
Upside
+15.942%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Takeda Pharmaceutical Co., Ltd. Company Profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
Compare TKPHF to Peers and Sector
Metrics to compare | TKPHF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTKPHFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.5x | 15.1x | −0.7x | |
PEG Ratio | 0.45 | 0.22 | 0.00 | |
Price/Book | 0.9x | 2.0x | 2.6x | |
Price / LTM Sales | 1.4x | 3.4x | 3.2x | |
Upside (Analyst Target) | - | 9.7% | 46.6% | |
Fair Value Upside | Unlock | 3.6% | 7.4% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 184.47
Dividend Yield
2.47%
Industry Median 1.74%
Annualised payout
0.6770
Paid unevenly
5-Years Growth
-
Growth Streak
FAQ
What Is the Takeda Pharmaceutical (TKPHF) Stock Price Today?
The Takeda Pharmaceutical stock price today is 27.365.
What Stock Exchange Does Takeda Pharmaceutical Trade On?
Takeda Pharmaceutical is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Takeda Pharmaceutical?
The stock symbol for Takeda Pharmaceutical is "TKPHF."
Does Takeda Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Takeda Pharmaceutical Co., Ltd. dividend yield is 2.39%.
What Is the Takeda Pharmaceutical Market Cap?
As of today, Takeda Pharmaceutical market cap is 43.56B.
What is Takeda Pharmaceutical Earnings Per Share?
The Takeda Pharmaceutical EPS is 184.47.
From a Technical Analysis Perspective, Is TKPHF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.